ACS Omega · 2020 · 16 citations · 21 references
PharmacyBioengineeringPharmaceuticsBiomaterialsDrug DeliveryNanoparticle Drug DeliveryAntimicrobial BiomaterialsDrug Delivery BiomaterialsDrug Delivery EngineeringDrug Delivery SystemsUrinary Tract Infection PharmacotherapyUrinary Tract InfectionsBioadhesive Drug DeliveryDrug Delivery NanocarriersMicroparticle Delivery SystemsMicroparticle Drug DeliveryMicroparticlesMicrosphere DeliveryMicrosphere Delivery SystemsMicrospheres
-glycolic acid) (PLGA) as a matrix were prepared. To reduce particle loss by washout, their surface was grafted with bioadhesive wheat germ agglutinin, providing biomimicry akin to UPEC. Since PLGA 503H has shown a slow drug release profile, the low-molecular-weight PLGA 2300 was studied. Whereas the drug loading of PLGA 503H particles amounted to 2.8%, the drug content of PLGA 2300 particles was twice as high. Although the drug release pattern started with an initial burst of 30% after 24 h for both PLGA types, half of the trimethoprim content was released after 4 days from PLGA 503H microparticles as opposed to 2 days in the case of PLGA 2300. Higher drug loading and accelerated release render PLGA 2300 a viable alternative to PLGA 503H.
21